HCPLive Network

Neurology

Articles
UnitedHealth Cutting More Docs Frm Medicare Advantage
UnitedHealth Group's Medicare Advantage network has begun notifying physicians of a new wave of cuts to its network, according to an article published June 17 in Medical Economics.
Articles
Early Research Shows Benefit for Enzyme Inhibitor in Stroke Victims
Minutes and seconds can make a difference in the amount of brain damage suffered by a stroke patient, but now scientists have shown that medication can significantly help limit the damage.
Articles
Tips Offered for Improving Practice Productivity
Four steps can be utilized to improve practice productivity, according to an article published June 24 in Medical Economics
Articles
Higher Plasma Vitamin D May Cut Hypertension Risk
People who have genetic variants tied to low production of 25-hydroxyvitamin D (25[OH]D) have an increased risk of hypertension, according to a study published online June 26 in The Lancet Diabetes & Endocrinology.
Articles
30-Day Electrocardiogram Monitoring Ups Atrial Fibrillation After Stroke
For patients with ischemic stroke or transient ischemic attack, electrocardiogram (ECG) monitoring with a 30-day event-triggered recorder improves detection of atrial fibrillation, according to a study published June 26 in the New England Journal of Medicine.
Articles
AHS: Menopausal Transition Aggravates Migraine Headaches
Among women with migraines, the frequency of headaches increases during the menopausal transition, according to research presented at the annual meeting of the American Headache Society, held from June 26 to 29 in Los Angeles.

Articles
Wikipedia Drug Entries Not Up-to-Date
Patients frequently turn to digital media for drug information; however, many Wikipedia entries about medications aren't up-to-date and accurate, according to a perspective piece published in the June 26 issue of the New England Journal of Medicine.
Neurology
Genzyme Reattempts Relapsing-remitting Multiple Sclerosis Indication for Alemtuzumab
European regulators recently approved alemtuzumab to treat active relapsing-remitting multiple sclerosis, but the US Food and Drug Administration denied the drug for that indication last year.
ICE/ENDO
Testosterone Levels Impact Restful Sleep for Obese, Overweight Men
A new factor in sleep and sleep apnea among obese and overweight men was introduced by researchers at a recent conference, pointing to the man’s testosterone levels as helping determine sleep quality.
Articles
Multiple Sclerosis Drug Could Ease Chemo Patient Pain
Researchers in Saint Louis are examining the ways in which a drug already approved for multiple sclerosis could ease some of the pain associated with chemotherapy for cancer patients.
Conferences
American Academy of Neurology 2013 Annual Meeting
PAINWeek 2013
64th American Academy of Neurology Annual Meeting
2012 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC)
The 63rd Annual Meeting of the American Academy of Neurology
PAINWeek 2010
American Academy of Neurology 2009
International Conference on Alzheimer's Disease 2009
American Epilepsy Society 2008
Condition Centers